Loading clinical trials...
Loading clinical trials...
Evaluation of the Use of the Tissue Genesis® Icellator Cell Isolation System® ("Icellator") Autologous Adipose Stromal Vascular Fraction Cells as a Treatment for Post-Irradiated Induced Xerostomia in Head and Neck Cancer Patients
Conditions
Interventions
Stromal Vascular Fraction
Usual Care
Locations
1
United States
Midwestern Regional Medical Center
Zion, Illinois, United States
Start Date
November 1, 2018
Primary Completion Date
December 28, 2020
Completion Date
December 31, 2020
Last Updated
April 30, 2018
Lead Sponsor
Midwestern Regional Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions